Wishing you all the joys of the season! 
Europe Noninvasive Ventilation Masks Market Size and Forecast (2020 – 2030)
Europe Noninvasive Ventilation Masks Market Size and Forecast (2020 – 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Interfaces (Masks and Accessories), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), Usage (Pediatrics and Adults), Size (Large, Medium, and Small), Material (Silicon, Gel, and Others), Product Type (Single-Use and Reusable), End User (Hospitals, Critical and Acute Care Settings, Ambulatory Surgical Centers, and Others), and Country
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Non-invasive ventilation (NIV) is the delivery of oxygen (ventilation support) through a face mask, eliminating the need for an endotracheal airway. NIV provides comparable physiological benefits to conventional mechanical ventilation by reducing breathing work and improving gas exchange. The intervention is recognized as an effective treatment for respiratory failure in chronic obstructive pulmonary disease, cardiogenic pulmonary edema, and other respiratory conditions without complications, such as upper airway trauma, ventilator-associated pneumonia, respiratory muscle weakness, and sinusitis. Thus, the increasing prevalence of respiratory diseases will likely significantly impact the Europe noninvasive ventilation masks market forecast in the next few years.
Rising Prevalence of COPD Propels Europe Noninvasive Ventilation Masks Market Growth
Chronic obstructive pulmonary disease (COPD) is one of the most significant public health concerns. According to the article “Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany” published by the National Library of Medicine in 2022, Germany reported ∼ 6 million COPD cases. According to an article titled “What knows a frail Swiss population about chronic obstructive pulmonary disease?” published in 2021, about 400,000 people were affected by COPD in Switzerland.
Patients with underlying COPDs who suffer from exacerbation of their diseases and hypercapnic dyspnoea or respiratory failure are most likely to be successfully treated with noninvasive ventilation (NIV). NIV effectively relieves the pressure on the respiratory muscles, increases tidal volume, decreases respiratory rate, and reduces the work of diaphragmatic breathing, resulting in an improvement in oxygen supply, a decrease in hypercapnia, and an improvement in dyspnea. A COPD is ideal for NIV as the treatment is quickly reversible, and additional support can be provided.
NIV reduces the endotracheal intubation rate, length of hospital stays, complications of mechanical ventilation, and mortality for COPD patients. Recent clinical practice guidelines recommend NIV as first-line ventilatory support for treating acute respiratory failure (ARF) in COPDs. NIV masks are increasingly used to treat people suffering from COPD and respiratory failure.
NIV helps reduce intubation and mortality in patients affected by COPD exacerbation with respiratory failure. The type of mask may impact the success rate. A full-face mask is recommended over nasal masks for patients who are seriously ill and suffer from ARF. Thus, Europe’s increasing prevalence of COPD and other respiratory disorders is expected to fuel the market’s growth.
Oral, oronasal, hybrid, nasal, nasal pillow, helmet, headgear, and other mask types can lead to patient discomfort, air leaks, claustrophobia, skin redness, eye irritation, skin breakdown, and facial deformity in children. A small leak at the bottom of the mask does not affect NIV’s performance. However, a large leak or a leak in the eye of mask can be a concern. Pain on the nose bridge indicates that the mask is too tight or is poorly fitting at the top. The mask must be readjusted or replaced, as the pain can worsen.
Pressure ulcers associated with NIV masks are a significant clinical problem due to the increasing popularity of the intervention. The development of pressure ulcers is associated with poor clinical outcomes, increased complications, and extended hospital stays, all of which aggravate the consequences of acute illness.
It is essential to make sure that the mask fits properly. Otherwise, oxygen may leak into the eyes, causing irritation and conjunctivitis. Using a full-face mask can interfere with coughing and effectively eliminate secretions. In addition, the excess pressure generated can affect the patient’s ability to generate sufficient expiratory flow rates, adversely impacting the mobilization of secretions and cough resistance that leads to the retention of secretions.
Thus, side effects associated with NIV masks hamper the growth of the Europe non-invasive ventilation masks market.
The Europe noninvasive ventilation masks market analysis has been carried out by considering the following segments: interfaces, application, usage, material, size, product type, and end user. By interfaces, the market is bifurcated into masks and accessories. The masks segment consists of a nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. Face mask is further sub-segmented into CO2 venting face mask and non-vented face mask. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. Based on application, the Europe non-invasive ventilation masks market is segmented into respiratory dysfunction, chronic obstructive pulmonary disease, pneumonia, and others. Based on the usage, the market is further segmented into pediatrics and adults. The Europe non-invasive ventilation masks market, by size, is further segmented into large, medium, and small. Based on material, it is further segmented into silicon, gel, and others. Based on product type, the market is bifurcated into single-use and reusable. Based on end user, the market is segmented into hospitals, critical and acute care settings, ambulatory surgical centers, and others. The scope of Europe noninvasive ventilation masks market report includes assessing the market performance in the UK, Germany, France, Austria, Switzerland, and the Rest of Europe.
European Union (EU) and World Health Organization (WHO) are key primary and secondary sources referred to while preparing the report on the Europe noninvasive ventilation masks market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our new research study on “Europe Noninvasive Ventilation Masks Market Forecast to 2030 – Regional Analysis – by Interfaces, Application, Usage, Size, Material, Product Type and End User,” the market is expected to grow from US$ 719.83 million in 2022 to US$ 1,076.68 million by 2030; it is anticipated to record a CAGR of 5.2% from 2022 to 2030. The Europe noninvasive ventilation masks market report emphasizes the trends prevalent in the market, along with drivers and deterrents impacting its growth.
Increasing prevalence of chronic obstructive pulmonary diseases and rising inclination toward home healthcare propel the Europe noninvasive ventilation masks market growth. However, the side effects associated with NIV masks hamper the market growth. Technological advancement is expected to bring new market trends in the coming years.
Growing Inclination Toward Home Healthcare Propels Europe Noninvasive Ventilation Masks Market Growth
The World Health Organization (WHO) defines home-based care as a series of services, including psychosocial, physical, or palliative care activities, provided to people in their homes. A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in greater chances of better, consistent, and timely interaction between patient and doctor owing to the growing prominence of cloud and mobility-driven medical devices. The COVID-19 outbreak crisis has triggered the importance of home healthcare due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. By monitoring a patient’s vitals remotely, healthcare professionals can avoid admissions to healthcare facilities. If the cases can be handled virtually, beds are reserved only for patients requiring critical care, which allows hospital administrations to manage their resources more effectively. NIV masks are used to treat altered control of breathing, non-acute upper airway obstruction, neuromuscular weaking such as spinal muscular atrophy (SMA), and partial upper spinal cord disorder. SMA is one of the most common genetic disorders detected in Germany. According to the study titled “Spinal muscular atrophy: best practice of diagnostic, newborn screening and therapy,” ~1 in 7,000 newborns suffers from SMA in Germany. Patients suffering from these conditions do not need to be admitted to the hospital for long. Companies are focusing on developing personalized home ventilator equipment for the treatment of these and other non-acute respiratory diseases. Thus, the rising inclination toward home healthcare for the treatment of respiratory disorders contributes to the growing Europe noninvasive ventilation masks market size.
Based on interfaces, the Europe noninvasive ventilation masks market is bifurcated into masks and accessories. The masks segment consists of nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. In 2022, the masks segment held a larger share of the market and is expected to record a higher CAGR during 2022–2030.
Europe Noninvasive Ventilation Masks Analysis Based on Segmental Evaluation:
Based on application, the Europe noninvasive ventilation masks market is segmented into respiratory dysfunction, chronic obstructive pulmonary disease, pneumonia, and others. In 2022, the respiratory dysfunction segment held the largest Europe noninvasive ventilation masks market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.
Based on usage, the Europe noninvasive ventilation masks market is bifurcated into pediatrics and adults. In 2022, the adults segment held a larger market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030. Patients aged 65 years and above tend to have more comorbid chronic diseases and disabilities. These individuals need age-appropriate management to reduce the risk of adverse events during hospitalization. NIV can be used to decrease reintubation rate and ICU mortality in subjects who are at risk of developing post-extubation respiratory failure. The NIV can be used as a preventative measure in ICU patients who have been extubated but are at high risk of developing post-extubation respiratory failure as it shortens the duration of invasive ventilation to prevent extubation failure. In addition, the intubation rates, mortality, and length of stay in the ICU can be reduced significantly by using NIV, which also reduces infective complications such as ventilator-associated pneumonia in adults. Also, the increasing prevalence of respiratory diseases due to pollution and smoking in adults fuels the market growth for the adult segment.
Based on size, the Europe noninvasive ventilation masks market is segmented into large, medium, and small. In 2022, the medium segment held the largest share of the market and is expected to record the highest CAGR during 2022–2030. Large and medium-size masks are used to treat adults. Growing pollution and smoking are responsible for increasing cases of respiratory diseases and lung-related diseases. Thus, the rising prevalence of respiratory diseases such as COPD, ARF, asthma, and hospital-acquired pneumonia in adults fuels the demand for large and medium-size masks. Furthermore, in patients affected by severe acute asthma, the addition of NIV to conventional treatment improves lung function and alleviates the exacerbation faster. In patients suffering from COPD, neuromuscular diseases, and obesity hypoventilation syndrome, noninvasive positive pressure ventilation (NIPPV) results in lower mortality, intubations, hospital admissions, and better quality of life. Also, the increase in cases of neurodegenerative diseases and sleep apnea in adults drives the market growth for the segment
Based on material, the Europe noninvasive ventilation masks market is segmented into silicon, gel, and others. In 2022, the silicon segment held the largest market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.
Based on product type, the Europe noninvasive ventilation masks market is bifurcated into single-use and reusable. In 2022, the reusable segment held a larger market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030. The reusable noninvasive ventilation masks are intended for multipatient use in a hospital and clinic. The masks are used after proper recommended cleaning procedures. The regulatory agency closely monitors the cleaning procedures of the reusable masks. Cleaning, disinfection, and sterilization of the mask need to be done in accordance with ISO 17664. The masks can be thermally disinfected with hot steam at a particular temperature or chemically disinfected with the disinfectants and can be autoclaved for full sterilization to be used again. The reusable masks contain adjustable headgear, dual-wall cushion, transparent frame, quick-release clips, and adjustable forehead support. The reusable masks help healthcare facilities reduce the cost of consumables and provide non-invasive and comfortable ventilation to the patients. These masks can have a non-vented adapter for the hospital and acute conditions as well as a vented adapter for discharge and long-term non-invasive ventilation that is equipped with an additional pressure measurement port and a rotating sleeve. These types of masks are lightweight, comfortable, and easy to use, and assist in providing therapy that helps patients remain compliant during long-term noninvasive ventilation.
The Europe noninvasive ventilation masks market, by end user, is segmented into hospitals, critical and acute care settings, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest share of the market and is expected to record the highest CAGR during 2022–2030.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe noninvasive ventilation masks market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe noninvasive ventilation masks market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the Europe noninvasive ventilation masks market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Non-Invasive Ventilation Masks Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Non-Invasive Ventilation Masks Market – Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Non-Invasive Ventilation Masks Market – Europe Market Analysis
6.1 Non-Invasive Ventilation Masks – Europe Market Overview
6.2 Non-Invasive Ventilation Masks – Europe Market and Forecast to 2031
7. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Interfaces, 2020-2030
7.1 Overview
7.2 Masks
7.2.1 Nasal Mask
7.2.2 Face Mask
7.2.2.1 CO2 Venting
7.2.3.1 Non-Vented
7.2.3 Nasal Pillow Mask
7.2.4 Oral Mask
7.2.5 Total face Mask/Helmets
7.3 Accessories
7.3.1 Elbows and replacement elbows
7.3.2 Hoses
7.3.3 Tubes
7.3.4 Skin barriers
7.3.5 Under/over the nose cushions
7.3.6 Head strap/replacement gears
8. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Application, 2020-2030
8.1 Overview
8.2 Respiratory Dysfunction
8.3 Chronic Obstructive Pulmonary Diseases
8.4 Pneumonia
8.5 Others
9. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Usage, 2020-2030
9.1 Overview
9.2 Paediatric
9.3 Adult
10. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Size, 2020-2030
10.1 Overview
10.2 Large
10.3 Medium
10.4 Small
11. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Material, 2020-2030
11.1 Overview
11.2 Silicon
11.3 Gel
11.4 Others
12. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Product Type, 2020-2030
12.1 Overview
12.2 Single Use
12.3 Reusable
13. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By End User, 2020-2030
13.1 Overview
13.2 Hospitals
13.3 Critical and Acute Care Settings
13.4 Ambulatory Surgical Centers
13.5 Others
14. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million), 2020-2030 – Country Analysis
14.1 Europe
14.1.1 Europe Non-Invasive Ventilation Masks Market Overview
14.1.2 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts to 2031
14.1.3 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Interfaces
14.1.4 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Application
14.1.5 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Usage
14.1.6 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Size
14.1.7 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Material
14.1.8 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Product Type
14.1.9 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By End User
14.1.10 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis – By Countries
14.1.10.1 Germany Non-Invasive Ventilation Masks Market
14.1.10.1.1 Germany Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.1.2 Germany Non-Invasive Ventilation Masks Market, by Application
14.1.10.1.3 Germany Non-Invasive Ventilation Masks Market, by Usage
14.1.10.1.4 Germany Non-Invasive Ventilation Masks Market, by Size
14.1.10.1.5 Germany Non-Invasive Ventilation Masks Market, by Material
14.1.10.1.6 Germany Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.1.7 Germany Non-Invasive Ventilation Masks Market, by End User
14.1.10.2 France Non-Invasive Ventilation Masks Market
14.1.10.2.1 France Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.2.2 France Non-Invasive Ventilation Masks Market, by Application
14.1.10.2.3 France Non-Invasive Ventilation Masks Market, by Usage
14.1.10.2.4 France Non-Invasive Ventilation Masks Market, by Size
14.1.10.2.5 France Non-Invasive Ventilation Masks Market, by Material
14.1.10.2.6 France Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.2.7 France Non-Invasive Ventilation Masks Market, by End User
14.1.10.3 Italy Non-Invasive Ventilation Masks Market
14.1.10.3.1 Italy Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.3.2 Italy Non-Invasive Ventilation Masks Market, by Application
14.1.10.3.3 Italy Non-Invasive Ventilation Masks Market, by Usage
14.1.10.3.4 Italy Non-Invasive Ventilation Masks Market, by Size
14.1.10.3.5 Italy Non-Invasive Ventilation Masks Market, by Material
14.1.10.3.6 Italy Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.3.7 Italy Non-Invasive Ventilation Masks Market, by End User
14.1.10.4 Spain Non-Invasive Ventilation Masks Market
14.1.10.4.1 Spain Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.4.2 Spain Non-Invasive Ventilation Masks Market, by Application
14.1.10.4.3 Spain Non-Invasive Ventilation Masks Market, by Usage
14.1.10.4.4 Spain Non-Invasive Ventilation Masks Market, by Size
14.1.10.4.5 Spain Non-Invasive Ventilation Masks Market, by Material
14.1.10.4.6 Spain Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.4.7 Spain Non-Invasive Ventilation Masks Market, by End User
14.1.10.5 United Kingdom Non-Invasive Ventilation Masks Market
14.1.10.5.1 United Kingdom Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.5.2 United Kingdom Non-Invasive Ventilation Masks Market, by Application
14.1.10.5.3 United Kingdom Non-Invasive Ventilation Masks Market, by Usage
14.1.10.5.4 United Kingdom Non-Invasive Ventilation Masks Market, by Size
14.1.10.5.5 United Kingdom Non-Invasive Ventilation Masks Market, by Material
14.1.10.5.6 United Kingdom Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.5.7 United Kingdom Non-Invasive Ventilation Masks Market, by End User
14.1.10.6 Austria Non-Invasive Ventilation Masks Market
14.1.10.6.1 Austria Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.6.2 Austria Non-Invasive Ventilation Masks Market, by Application
14.1.10.6.3 Austria Non-Invasive Ventilation Masks Market, by Usage
14.1.10.6.4 Austria Non-Invasive Ventilation Masks Market, by Size
14.1.10.6.5 Austria Non-Invasive Ventilation Masks Market, by Material
14.1.10.6.6 Austria Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.6.7 Austria Non-Invasive Ventilation Masks Market, by End User
14.1.10.7 Switzerland Non-Invasive Ventilation Masks Market
14.1.10.7.1 Switzerland Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.7.2 Switzerland Non-Invasive Ventilation Masks Market, by Application
14.1.10.7.3 Switzerland Non-Invasive Ventilation Masks Market, by Usage
14.1.10.7.4 Switzerland Non-Invasive Ventilation Masks Market, by Size
14.1.10.7.5 Switzerland Non-Invasive Ventilation Masks Market, by Material
14.1.10.7.6 Switzerland Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.7.7 Switzerland Non-Invasive Ventilation Masks Market, by End User
14.1.10.8 Rest of Europe Non-Invasive Ventilation Masks Market
14.1.10.8.1 Rest of Europe Non-Invasive Ventilation Masks Market, by Interfaces
14.1.10.8.2 Rest of Europe Non-Invasive Ventilation Masks Market, by Application
14.1.10.8.3 Rest of Europe Non-Invasive Ventilation Masks Market, by Usage
14.1.10.8.4 Rest of Europe Non-Invasive Ventilation Masks Market, by Size
14.1.10.8.5 Rest of Europe Non-Invasive Ventilation Masks Market, by Material
14.1.10.8.6 Rest of Europe Non-Invasive Ventilation Masks Market, by Product Type
14.1.10.8.7 Rest of Europe Non-Invasive Ventilation Masks Market, by End User
15. Industry Landscape
15.1 Mergers and Acquisitions
15.2 Agreements, Collaborations, Joint Ventures
15.3 New Product Launches
15.4 Expansions and Other Strategic Developments
16. Competitive Landscape
16.1 Heat Map Analysis by Key Players
16.2 Company Positioning and Concentration
17. Non-Invasive Ventilation Masks Market – Key Company Profiles
17.1 SunMED Medical
17.1.1 Key Facts
17.1.2 Business Description
17.1.3 Products and Services
17.1.4 Financial Overview
17.1.5 SWOT Analysis
17.1.6 Key Developments
Note – Similar information would be provided for below list of companies
17.2 ResMed
17.3 Armstrong Medical Ltd
17.4 Koninklijke Philips N.V.
17.5 Ambu A/S
17.6 Drägerwerk AG and Co. KGaA
17.7 DEAS S.R.L.
17.8 Fisher and Paykel Healthcare Limited
17.9 Intersurgical Ltd
17.10 Hamilton Medical
18. Appendix
18.1 Glossary
18.2 About The Insight Partners
18.3 Market Intelligence Cloud
LIST OF TABLES
Table 2. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 4. Europe: Non-Invasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 5. Europe: Non-Invasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 6. Europe: Non-Invasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 7. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 8. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 9. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 10. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 11. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 12. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 13. Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Country
Table 14. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 15. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 16. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 17. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 18. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 19. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 20. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 21. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 22. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 23. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 24. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 25. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 26. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 27. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 28. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 29. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 30. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 31. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 32. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 33. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 34. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 35. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 36. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 37. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 38. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 39. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 40. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 41. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 42. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 43. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 44. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 45. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 46. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 47. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 48. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 49. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 50. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 51. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 52. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 53. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 54. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 55. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 56. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 57. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 58. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 59. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 60. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 61. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 62. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 63. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 64. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 65. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 66. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 67. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 68. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 69. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 70. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 71. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 72. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 73. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 74. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 75. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 76. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 77. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 78. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 79. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 80. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 81. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 82. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 83. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 84. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Interfaces
Table 85. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Masks
Table 86. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Face Mask
Table 87. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Accessories
Table 88. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 89. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Usage
Table 90. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Size
Table 91. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Material
Table 92. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 93. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 94. Glossary of Terms, Track and Trace Market
LIST OF FIGURES
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Noninvasive Ventilation Masks Market Revenue (US$ Million), 2022–2030
Figure 5. Europe Noninvasive Ventilation Masks Market Share (%) – by Interfaces, 2022 and 2030
Figure 6. Masks: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 7. Accessories: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe Noninvasive Ventilation Masks Market Share (%) – by Application, 2022 and 2030
Figure 9. Respiratory Dysfunction: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chronic Obstructive Pulmonary Diseases: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 11. Pneumonia: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Noninvasive Ventilation Masks Market Share (%) – by Usage, 2022 and 2030
Figure 14. Paediatric: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 15. Adult: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Noninvasive Ventilation Masks Market Share (%) – by Size, 2022 and 2030
Figure 17. Large: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 18. Medium: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 19. Small: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Noninvasive Ventilation Masks Market Share (%) – by Material, 2022 and 2030
Figure 21. Silicon: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 22. Gel: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe Noninvasive Ventilation Masks Market Share (%) – by Product Type, 2022 and 2030
Figure 25. Single Use: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 26. Reusable: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe Noninvasive Ventilation Masks Market Share (%) – by End User, 2022 and 2030
Figure 28. Hospitals: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 29. Critical and Acute Care Settings: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 30. Ambulatory Surgical Centers: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Europe Noninvasive Ventilation Masks Market– Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe Noninvasive Ventilation Masks Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 33. Germany: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Austria: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Switzerland: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. United Kingdom: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. France: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Italy: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Spain: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Rest of Europe: Europe Noninvasive Ventilation Masks Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – Europe Noninvasive Ventilation Masks Market
o Fisher & Paykel Healthcare Ltd
o Armstrong Medical Ltd
o Intersurgical Ltd
o Hamilton Medical
o ResMed
o Koninklijke Philips NV
o Ambu AS
o Dragerwerk AG & Co KGaA
o DEAS S.R.L
o SunMed Group Holdings LLC
You must be logged in to post a review.
Reviews
There are no reviews yet.